Exhibit 10.35 THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THIS WARRANT ------------------------------------------------------------Igi Inc • August 24th, 1998 • Biological products, (no disgnostic substances) • Delaware
AMENDMENT TO EMPLOYMENT AGREEMENT THIS AGREEMENT dated as of the 1st day of October 1997, between IGI, Inc., a Delaware corporation having its principal place of business at Wheat Road and Lincoln Avenue, Buena NJ 08310 (the "Company") and John P....Employment Agreement • November 13th, 1997 • Igi Inc • Biological products, (no disgnostic substances)
Exhibit 99.1 FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT ----------------------------------------------- This Fourth Amendment to Loan and Security Agreement (this "Agreement") dated as of February 28, 2001 by and between Fleet Capital Corporation...Loan and Security Agreement • April 20th, 2001 • Igi Inc • Biological products, (no disgnostic substances) • Pennsylvania
WITNESSETH ----------License Agreement • April 14th, 2004 • Igi Inc • Biological products, (no disgnostic substances) • New Jersey
Exhibit 11.03 MEMORANDUM OF AGREEMENT ----------------------- * PARTIES:. IGI, Inc. ("IGI") and Michael F. Holick, MD, Ph.D. ("Holick") * EXCLUSIVE LICENSE AGREEMENT:.On or before December 31, 2003, IGI and Holick shall enter into an Exclusive License...Memorandum of Agreement • November 12th, 2003 • Igi Inc • Biological products, (no disgnostic substances)
RECITALSSeverance Agreement • August 13th, 2004 • Igi Inc • Biological products, (no disgnostic substances)
WARRANTIgi Inc • April 14th, 2000 • Biological products, (no disgnostic substances) • Delaware
IGI, INC.Igi Inc • April 12th, 1999 • Biological products, (no disgnostic substances) • Delaware
ARTICLE IAsset Purchase Agreement • February 7th, 2002 • Igi Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.70 THIS LOAN AGREEMENT dated as of January 10,2002, by and between the NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY (the "Authority"), a public body corporate and politic constituting an instrumentality of the State of New Jersey Department of...Loan Agreement • March 10th, 2003 • Igi Inc • Biological products, (no disgnostic substances) • New Jersey
BACKGROUNDLoan and Security Agreement • April 14th, 2000 • Igi Inc • Biological products, (no disgnostic substances) • Pennsylvania
1 EXHIBIT *(10.31) PLEDGE AGREEMENT This Pledge Agreement ("Pledge Agreement") is made by IGEN, INC. ("Pledgor") and delivered to FLEET CAPITAL CORPORATION ("Lender") and is given and is intended to provide additional security for all Obligations...Pledge Agreement • April 14th, 2000 • Igi Inc • Biological products, (no disgnostic substances) • Pennsylvania
1 2 1. Defined Terms. Capitalized terms used herein, but not defined, shall have the same meaning as ascribed to such terms in the Purchase Agreement.Pledge and Security Agreement • April 14th, 2000 • Igi Inc • Biological products, (no disgnostic substances) • Maryland
RECITALSLicense Agreement • April 14th, 2004 • Igi Inc • Biological products, (no disgnostic substances) • Florida
IGI, INC.Igi Inc • April 12th, 1999 • Biological products, (no disgnostic substances) • Delaware
Exhibit 10.101 EMPLOYMENT AGREEMENT THIS AGREEMENT, dated as of September 26, 2003, by and between IGI, Inc., a Delaware corporation (the "Company"), located at 105 Lincoln Avenue, Buena, New Jersey, 08310, and Michael F. Holick, MD, Ph.D ("Holick")...Employment Agreement • April 14th, 2004 • Igi Inc • Biological products, (no disgnostic substances) • New Jersey
BACKGROUND ----------Forbearance Agreement • August 24th, 1998 • Igi Inc • Biological products, (no disgnostic substances) • New Hampshire
EXHIBIT 10.95 SUPPLEMENTAL AGREEMENT This Supplemental Agreement dated May 31, 2002 is made by and between Vetoquinol U.S.A., Inc. ("Buyer") and IGI, Inc. ("Seller"). W I T N E S S E T H: WHEREAS, Buyer and Seller entered into an Asset Purchase...Supplemental Agreement • March 10th, 2003 • Igi Inc • Biological products, (no disgnostic substances)
TELIGENT, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementTeligent, Inc. • January 28th, 2021 • Pharmaceutical preparations • New York
EIGHTH AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT AGREEMENT (this "Agreement"), made as of this 30th day of September, 1997, by and among FLEET BANK-NH, a trust company organized under the laws of New Hampshire ("Fleet"); MELLON BANK,...Loan Agreement • November 13th, 1997 • Igi Inc • Biological products, (no disgnostic substances) • New Hampshire
1 2 Upon the occurrence of an Event of Default, Lender shall have all of the rights and remedies set forth in Section 10 of the Loan Agreement or as available at law or in equity to protect and enforce Lender's rights hereunder.Igi Inc • April 14th, 2000 • Biological products, (no disgnostic substances)
BACKGROUND ----------Extension Agreement • August 24th, 1998 • Igi Inc • Biological products, (no disgnostic substances) • New Hampshire
SECTION 7. NO WAIVER BY LENDER. Except as otherwise expressly provided for herein, nothing in this Agreement shall extend to or affect in any way the Borrowers' obligations or the Lender's rights and remedies arising under the Loan Agreement or the...Loan and Security Agreement • November 14th, 2000 • Igi Inc • Biological products, (no disgnostic substances) • Pennsylvania
1 2 This Note shall be subject to mandatory prepayment (and prepayment premium, if applicable) in accordance with the provisions of Section 3.3 of the Loan Agreement. Borrower may also terminate the Loan Agreement and, in connection with such...Igi Inc • April 14th, 2000 • Biological products, (no disgnostic substances)
UNDERWRITING AGREEMENTUnderwriting Agreement • June 27th, 2014 • Igi Laboratories, Inc • Biological products, (no disgnostic substances) • New York
IGI Laboratories, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Roth Capital Partners, LLC and Oppenheimer & Co. Inc. are acting as representatives (the “Representatives”), an aggregate of 4,650,000 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.01 per share (the “Common Stock”), of the Company. The Company has granted the Underwriters the option to purchase an aggregate of up to 697,500 additional shares of Common Stock (the “Option Shares”) as may be necessary to cover over-allotments made in connection with the offering pursuant to Section 4(b) hereof. The Firm Shares and the Option Shares are collectively referred to as the “Shares.”
1 2 Upon the occurrence of an Event of Default, Lender shall have all of the rights and remedies set forth in Section 10 of the Loan Agreement or as available at law or in equity to protect and enforce Lender's rights hereunder.Igi Inc • April 14th, 2000 • Biological products, (no disgnostic substances)
RECITALSSeverance Agreement • April 14th, 2004 • Igi Inc • Biological products, (no disgnostic substances)
AGREEMENTConfidentiality Agreement • March 10th, 2003 • Igi Inc • Biological products, (no disgnostic substances) • Arizona
1- 2 2. Grantor hereby covenants and agrees to maintain the Trademarks in full force and effect and otherwise perform all of its obligations and undertakings under this Agreement until all of the Obligations are indefeasibly paid and satisfied in full...Trademark Security Agreement • April 14th, 2000 • Igi Inc • Biological products, (no disgnostic substances) • Pennsylvania
C. It is a condition precedent to the purchase of the Notes and the Warrants that the Grantors execute and deliver this Security Agreement. 2 AGREEMENTSecurity Agreement • April 14th, 2000 • Igi Inc • Biological products, (no disgnostic substances) • Maryland
Exhibit 10.1 AMENDMENT OF LICENSE AND SUPPLY AGREEMENT WHEREAS, IGI has been granted the exclusive license to certain proprietary rights and intellectual property (including pursuant to certain patents) to a lipid vesicle technology for topical...License and Supply Agreement • November 24th, 2004 • Igi Inc • Biological products, (no disgnostic substances)
EXHIBIT 10.79 TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT (United States Patents) TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT, dated as of May 30, 2002, by and between AMERICAN CAPITAL STRATEGIES, LTD., a Delaware corporation, with...Patent Security Agreement • March 10th, 2003 • Igi Inc • Biological products, (no disgnostic substances)
INDEMNIFICATION AGREEMENTIndemnification Agreement • March 19th, 2009 • Igi Inc • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of March 13, 2009 by and between IGI Laboratories, Inc., a Delaware corporation (the “Company”), and Joyce Erony (“Indemnitee”).
Exhibit 99.3 MANUFACTURING AND SUPPLY AGREEMENT This Manufacturing and Supply Agreement (the "Agreement"), dated as of ______________, 2002, is entered into by and among IGI, Inc., a Delaware corporation ("IGI"), Igen, Inc., a Delaware corporation...Manufacturing and Supply Agreement • February 7th, 2002 • Igi Inc • Biological products, (no disgnostic substances) • New Jersey
July 31, 1997 IGI, Inc. and Subsidiaries Wheat Road and Lincoln Avenue Buena, New Jersey 08310 Re: Seventh Amendment to Second Amended and Restated Loan Agreement --------------------------------------------------------------- Dear Sirs: Reference is...Igi Inc • November 13th, 1997 • Biological products, (no disgnostic substances)
